RARE DISEASERESEARCH ATLAS
Open navigation menu

ORPHA:1144

Arthrogryposis-like hand anomaly-sensorineural deafness syndrome

high confidenceDisorder

Also known as: Arthrogryposis-like hand anomaly-sensorineural hearing loss syndrome · Distal arthrogryposis type 6

Publications

6

16.4th percentile

Trials

0

Interventional, condition-specific

Researchers

30

Distinct authors in sample

Gene link

—

Readiness

2/6

Stages with a signal

Clinical definition (Orphanet)

A rare syndrome characterized by an arthrogryposis-like hand anomaly and sensorineural deafness. It has been described in only one family. Male-to-male transmission was observed.

How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.

Orphanet entry

Cross-references

Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.

Additional Mondo synonyms (1)

distal arthrogryposis type 6

Research stages

Trial readiness signals

Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”

2/6 stages with a signal

Research-stage checklist from open sources (GenCC, literature, Monarch when enriched, ClinicalTrials.gov). Not a prognosis or care recommendation.

  1. Gene identifiedNot found

    No GenCC disease–gene assertion in this build

  2. LiteraturePresent

    6 matched papers (3 in last 10 years) Source

  3. Phenotype characterisedPresent

    8 HPO annotations (e.g. Arachnodactyly; Sensorineural hearing impairment; Short stature) Source

  4. Animal modelNot found

    No Alliance genotype “model of” associations via Monarch for these Mondo IDs

  5. Orphan designationNot found

    No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source

  6. Interventional trialNot found

    No matched interventional trial under our ClinicalTrials.gov rules

Biology

Genes and phenotypes

Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.

Do we know what causes it?

Not yet — the cause hasn't been pinned down in GenCC.

No strong gene–disease assertion joined for this Orphanet entity.

Phenotypes (Monarch / HPO)

8

Associated phenotypes · MONDO:0007159

  • Arachnodactyly
  • Sensorineural hearing impairment
  • Short stature
  • Arthrogryposis-like hand anomaly

Showing 4 of 8 — open Monarch for the full list.

Animal models (Monarch / Alliance)

None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.

Monarch fetch 2026-07-29

Therapies

Designations, candidates, and chemicals

FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.

Orphan designation (FDA · EMA)

No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.

Open Targets candidates

No drugs or clinical candidates returned for this Mondo ID on Open Targets.

CTD chemicals (MyDisease.info)

No CTD chemical associations returned for this Mondo ID.

Literature

Is anyone studying this?

6

6 papers have ever been indexed under this name. For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.

6 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).

3 in the last 10 years · high confidence · 16.4th percentile (publications denominator)

Phrase hits: 6 · MeSH hits: 0

Open Europe PMC search

Who's working on it?

30

Distinct author names in 6 sampled papers — named people below.

Who's working on it?

No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.

  1. 01
    Ahsan T1 paper · 2022

    Molecular Biotechnology Division, National Institute of Biotechnology, Savar, Dhaka, 1349, Bangladesh.

    Papers in Europe PMC
  2. 02
    Akhteruzzaman S1 paper · 2022

    Department of Genetic Engineering & Biotechnology, University of Dhaka, Dhaka, 1000, Bangladesh.

    Papers in Europe PMC
  3. 03
    Bąbol-Pokora K1 paper · 2021

    Department of Pediatrics, Oncology and Hematology, Medical University of Lodz, Lodz, Poland.

    Papers in Europe PMC
  4. 04
    Bamshad M1 paper · 2009

    Division of Genetic Medicine, Department of Pediatrics, University of Washington, Seattle Children's Hospital, HSC RR349, Seattle, WA 98195, USA. mbamshad@u.washington.edu

    Papers in Europe PMC
  5. 05
    Bartek V1 paper · 2024

    Department of Obstetrics and Gynecology, Semmelweis University, 1085 Budapest, Hungary.

    Papers in Europe PMC
  6. 06
    Beke A1 paper · 2024

    Department of Obstetrics and Gynecology, Semmelweis University, 1085 Budapest, Hungary.

    Papers in Europe PMC
  7. 07
    Benkő Z1 paper · 2024

    Department of Obstetrics and Gynecology, Semmelweis University, 1085 Budapest, Hungary.

    Papers in Europe PMC
  8. 08
    Biswas A1 paper · 2022

    Department of Genetic Engineering & Biotechnology, University of Dhaka, Dhaka, 1000, Bangladesh.

    Papers in Europe PMC
  9. 09
    Caglar C1 paper · 2015

    Private Bagcilar Medicine Center, Department of Physical Medicine and Rehabilitation, 34204 Istanbul, Turkey.

    Papers in Europe PMC
  10. 10
    Harmath Á1 paper · 2024

    Department of Obstetrics and Gynecology, Semmelweis University, 1085 Budapest, Hungary.

    Papers in Europe PMC

Clinical research

Is a treatment being tested?

0

interventional trials for this specific condition

No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present).

Data as of 11 September 2026 · last trial check 11 September 2026

No matched interventional trials. This is true for 77.2% of diseases in the trials denominator (5501 of 7126). Here are the researchers publishing on it.

high confidence · 38.6th percentile (trials denominator)

Recruiting interventional trials

From the matched ClinicalTrials.gov set

No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.

See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.

Other registries (secondary)

Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.

raw 0 · after dedupe 0 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 0 · dropped 0 · fetched 2026-07-29

Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri

No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).

Where to find support

Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.

Orphanet entry for Arthrogryposis-like hand anomaly-sensorineural deafness syndrome — check Associations / patient organisations on that page.

India — NPRD

Last verified 2026-07-26

This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.

Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.

How we counted this

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.

"Arthrogryposis-like hand anomaly-sensorineural deafness syndrome" OR "Arthrogryposis-like hand anomaly-sensorineural hearing loss syndrome" OR "Distal arthrogryposis type 6"

Run this search on Europe PMC

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"Arthrogryposis-like hand anomaly-sensorineural deafness syndrome" OR "Arthrogryposis-like hand anomaly-sensorineural hearing loss syndrome" OR "Distal arthrogryposis type 6"

Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.

Query health: ok — strategies attempted: phrase; with hits: phrase

Run this search on ClinicalTrials.gov

Confidence reasoning

  • Preferred label is multi-word and distinctive
  • No synonyms dropped by stoplist
  • No label/synonym collisions with other diseases in this corpus

Ingested 2026-07-26T16:30:17.604Z